A Study of Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)
Condition(s):Extensive-stage Small Cell Lung CancerLast Updated:June 14, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Extensive-stage Small Cell Lung CancerLast Updated:June 14, 2022Completed
Condition(s):Recurrent Small Cell Lung CancerLast Updated:August 9, 2018Completed
Condition(s):Small Cell Lung CancerLast Updated:March 25, 2024Recruiting
Condition(s):Extensive Stage Small Cell Lung CancerLast Updated:March 10, 2021Unknown status
Condition(s):Small Cell Lung Cancer; Small Cell Lung Cancer RecurrentLast Updated:August 25, 2017Completed
Condition(s):Small Cell Lung CancerLast Updated:August 3, 2021Completed
Condition(s):Small Cell Lung Cancer; Angiogenesis; Chemotherapy EffectLast Updated:November 29, 2022Not yet recruiting
Condition(s):Relapsed Small Cell Lung CancerLast Updated:March 12, 2024Recruiting
Condition(s):Small Cell Lung CancerLast Updated:December 14, 2023Recruiting
Condition(s):Small Cell Lung CancerLast Updated:July 29, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.